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Abstract
Rapid diagnostics can be accurate but, often, those based on antibody detection for infectious diseases are unwittingly
underrated for various reasons. Herein, we described the development of a combined rapid test for two clinically-
indistinguishable bacterial diseases, typhoid and paratyphoid A fever, the latter fast emerging as a global threat. By using
monoclonal antibodies (mAbs) to bacterial antigens of known chemical structures as probes, we were able to dissect the
antibody response in patients at the level of monosaccharides. Thus, a mAb specific for a common lipopolysaccharide
antigen (O12) found in both the causative organisms was employed to semi-quantify the amounts of anti-O12 antibodies
present in both types of patients in an epitope-inhibition particle-based (TUBEX) immunoassay. This colorimetric assay
detected not only anti-O12 antibodies that were abundantly produced, but also, by steric hindrance, antibodies to an
adjoining epitope (O9 or O2 in the typhoid or paratyphoid bacillus, respectively). Sensitivity and, particularly, reaction
intensities, were significantly better than those obtained using an anti-O9 or anti-O2 mAb-probe in the examination of
paired sera from 22 culture-confirmed typhoid patients (sensitivity, 81.8% vs 75.0%) or single sera from 36 culture-confirmed
paratyphoid patients (52.8% vs 28.6), respectively. Importantly, sensitivity was better (97.1% for typhoid, 75.0% for
paratyphoid) if allowance was made for the absence of relevant antibodies in certain specimens as determined by an
independent, objective assay (ELISA) — such specimens might have been storage-denatured (especially the older
paratyphoid samples) or procured from non-responders. Benchmarking against ELISA, which revealed high concordance
between the two tests, was useful and more appropriate than comparing with culture methods as traditionally done, since
antibody tests and culture target slightly different stages of these diseases. Paired sera analysis was insightful, revealing 64%
of typhoid patients who had no change in antibody titer over 4–16 days, and 14% with no IgM-IgG class-switching.
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Introduction
Sensitivity and specificity characterize how clinically useful an
immunodiagnostic (serological) test is. For acute infectious
diseases, these parameters are usually computed by comparing
the results obtained from such a test with those derived by culture
of the infectious agent from the study cohort. This time-honored
use of culture as the gold standard in diagnosis has seldom been
questioned even though in many situations, culturing is neither
sensitive nor practicable [1,2,3]. This raises the possibility that, in
some cases, the real worth of immunodiagnostic tests could be
unfairly benchmarked. Another factor often taken for granted
which, too, can adversely affect the perceived performance of
immunodiagnostic tests is the quality of the specimen used for
analysis, particularly if, as is often done, the specimen has been
procured years ago and stored away.
We addressed the above issues in the present study using
typhoid fever as the model disease. This is historically appropriate
because the first immunodiagnostic test in the world—the Widal
test [4]—was developed for typhoid, a test that is still widely used
today. Typhoid has remained a major health threat globally,
affecting some 20 million people annually [5]. A related disease,
paratyphoid fever A, which resembles typhoid fever clinically and
which is probably under-diagnosed, has recently emerged to be as
dangerous as typhoid fever [6]. Study of both diseases together
allows assay sensitivity and specificity to be addressed more
comprehensively, while the availability of detailed information
regarding both of the infecting organisms, including, in parti-
cular, the relevant antigens, permits high-resolution analysis of
specificity.
Thus, the organisms that cause typhoid and paratyphoid A
fever, Salmonella enterica serotype Typhi (S. Typhi) and S. Paratyphi
A, respectively, belong to a large family of Salmonella organisms.
There are about 2,000 members or serotypes differentiated by the
surface ‘‘O’’ and ‘‘H’’ antigens found in the lipopolysaccharide
(LPS) and flagella, respectively, of these bacteria. Serotypes with a
common immunodominant ‘‘O’’ antigen are grouped together [7].
Thus, S. Typhi belongs to serogroup D in which the common
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serogroup A which has O2 and O12. Another member which
causes paratyphoid fever but found infrequently and only in
certain geographical regions, S. Paratyphi B, belongs to serogroup
B (O4 and O12). A third paratyphoid member, S. Paratyphi C,
which is also infrequently found and causes a milder disease,
belongs to serogroup C (O6 and O7). All other serotypes of
Salmonella are usually not invasive and cause a less debilitating local
infection in the gut.
An understanding of the pathogenesis of typhoid fever is
germane to the appreciation of assay sensitivity and specificity.
Thus, disease is initiated following ingestion of S. Typhi organisms,
which then multiply in the mesenteric tissues before disseminating
into the bloodstream and seeding the various organs, all taking a
week or two usually [8]. At this early stage, the organism is readily
recovered from the circulation while antibody production to the
organism may have only just begun, starting with IgM antibodies.
As the disease progresses into late phase and convalescence after,
usually, 3–4 weeks, the organism circulates only infrequently in the
blood while antibodies, on the other hand, become increasingly
abundant. As the disease terminates, the organism disappears
completely from the host and pathogen-specific IgM antibodies
also subside steadily in levels, but IgG antibodies can remain
elevated for months thereafter. However, in about 5% of typhoid
patients who become chronic carriers following remission, the
organism hides away in the gall bladder and persists indefinitely.
Detailed chemical structures of the ‘‘O’’ antigens have long
been known [9]. Importantly, many of the antigens are specified
by only a few sugar molecules. This allows precise analysis of
specificities to be made at the level of monosaccharides. For
example, O9 is specified largely by an unusual sugar located at the
end of a repeating oligosaccharide chain in the LPS. This is
tyvelose, a dideoxymannose, which adjoins a trisaccharide in the
chain (mannose-rhamnose-galactose) that specifies the O12
antigen. O12 is also present in S. Paratyphi A and S. Paratyphi
B, but in these organisms, O9 is substituted by O2 (paratose) and
O4 (abequose), respectively. Both paratose and abequose are
structurally identical to tyvelose except for the stereoisomeric
orientation of an –OH group (Steinbacher, 1996). Uniquely, these
dideoxyhexoses (LPS as a whole) are thymus-independent type 1
antigens which stimulate strong and rapid IgM antibody responses
even in infants [10].
The Widal test is the first to exploit the unique attributes of the
‘‘O’’ antigens to detect serum antibodies from typhoid patients,
but because whole bacterial cells are employed in agglutination
tests, this test is neither sensitive nor specific [11,12]. Better
performance is observed when purified LPS extracted from S.
Typhi organisms is used in ELISA tests [13]. We exploit the high
specificity of these antigens in a more precise manner, by utilizing
monoclonal antibodies (mAbs) to the various ‘‘O’’ antigens in
conjunction with whole LPS in epitope-inhibition assays. Thus,
anti-O9 antibodies in patients are detected by their ability to
inhibit the binding between an anti-O9 mAb and the O9 antigen
in the LPS. For easy and rapid visualization, the mAb is coupled to
blue-colored indicator particles, and the LPS to magnetic particles.
Following brief and vigorous agitation in V-shaped microwells, the
reaction mixture comprising test serum and reagent particles is
placed on a magnet stand to sediment the magnetic particles.
Indicator particles bound to these will be co-sedimented. Thus,
presence of infection-specific antibodies will be revealed by the
resultant concentration (color) of indicator particles left in the
suspension. A background color (red) is added so that results are
visually and semi-quantitatively read based on varying mixtures of
blue and red.
TUBEX TFH (IDL Biotech, Bromma, Sweden) is the first
application of the above diagnostic system. It uses an anti-O9 mAb
(3h1) to detect typhoid fever, and results are scored against a color
chart with a scale of 0 to 10 (score ‘0’, negative and most red; score
‘10’, most positive and most blue). Reasonable sensitivities (75–
90%) and specificities (70–97%) have been observed [12–17].
More recently, we developed a prototypic test (TUBEX PA) for
paratyphoid A fever which employed an anti-O2 mAb (P1D10)
and S. Paratyphi A LPS, which also yielded reasonable sensitivities
(81–93%) [18]. However, a surprising finding from this study was
that TUBEX PA could also detect typhoid patients in about 50%
of cases, and the converse was true with TUBEX TF in regard to
paratyphoid A patients. We reasoned that this mutual cross-
detection was due to the presence of anti-O12 antibodies in both
cases, the possibility being that these antibodies could interfere in
the test by steric hindrance due to the close proximity of the O12
and O9 or O2 antigens.
In the present study, we exploited the presence of anti-O12
antibodies in both typhoid and paratyphoid A patients to establish
a combined TUBEX test for these diseases. An anti-O12 mAb was
thus employed, which impressively, proved to be a highly sensitive
indicator. Sensitivity is attributed to the abundance of anti-O12
antibodies in these patients, which appeared to consist of at least 2
sub-populations, as well as the fact that anti-O9 and anti-O2
antibodies are also detected in the combined test by virtue of steric
hindrance. An important revelation is that the type or quality of
specimen used can seriously affect the sensitivity of the assay. We
found inclusion of an independent and objective test such as
ELISA to be extremely important since this can serve both as a
check on specimen quality and as a performance yardstick for the
rapid test.
Results
Preliminary studies show O12 indicator more sensitive
than O9 or O2 indicator
We prepared blue latex particles coupled with the anti-O12
mAb (P4E8) and examined the performance of these as substitute
indicator particles in various TUBEX tests (see Fig. 1). First, we
compared the sensitivity of detection of purified mAbs by this O12
indicator (TUBEX 12T) with the O9 indicator (also blue-colored;
TUBEX TF), both situations using S. Typhi LPS as substrate. It is
evident that the O12 indicator detected the anti-O9 mAb (3h1) as
efficiently (32 mg/ml) as the O9 indicator (Fig. 2A). While the O12
indicator also detected the anti-O12 mAb (P4E8) at a similar
sensitivity, interestingly, the O9 indicator was not able to detect
this mAb. When both inhibiting mAbs were used together, the O9
indicator detected this combination no better than detecting 3h1
alone; in contrast, increased sensitivity (16 mg/ml) and increased
intensity of reaction were observed using the O12 indicator. When
both the O12 and O9 indicators were used together in the test,
results similar to or marginally better than those using the O12
indicator alone were obtained (Fig. 2A).
Second, we compared the performance of the O12 indicator
(TUBEX 12P) with the O2 indicator (coupled with mAb P1D10;
TUBEX PA) both using S. Paratyphoid A LPS, to detect purified
mAbs (anti-O2 and anti-O12). The results obtained (Fig. 2B) were
very similar to those obtained above in Fig. 2A, demonstrating the
greater sensitivity of the O12 indicator over the O2 indicator.
Third, we examined the performance of O12 indicator-based
TUBEX tests in the examination of stored serum samples from 3
typhoid patients (Fig. 3A). In the 1
st specimen (T1), both TUBEX
12P (which primarily detects anti-O12 antibodies) and TUBEX
TF (which primarily detects anti-O9 antibodies), were weakly
Typhoid-Paratyphoid Rapid Test
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(see bottom of figure). Using both the O12 and O9 indicators
together enhanced the reaction only marginally. The importance
of anti-O12 antibodies to the reaction is also seen in specimen
T2—higher readings in TUBEX 12P (score 9) than those of
TUBEX PA or TUBEX TF (both, score 4). Similarly, in specimen
T3, higher readings were obtained using the O12 indicator (score
7) instead of the O9 indicator (score 4). In all cases, the TUBEX
tests were negative for sera obtained from healthy individuals.
Finally, O12 indicator-based TUBEX tests were used to
examine stored sera from 6 paratyphoid A patients (Fig. 3B).
Remarkably, TUBEX 12P detected all 6 sera at the highest
intensity (score 10), whereas TUBEX PA detected these with
significantly lower readings, especially in PA6 (score 2) and PA4
(score 5). This may be attributed to the additional detection of
certain types of anti-O12 antibodies by TUBEX 12P (both tests
can detect anti-O2 antibodies). Since TUBEX 12T detects the
same anti-O12 antibodies as TUBEX 12P but not anti-O2
antibodies, the high scores seen in TUBEX 12P may be due to the
complementation between TUBEX PA and TUBEX 12T. Thus,
patient PA6 has a low TUBEX PA score of 2 but a high TUBEX
12T score of 9, while the converse is true of patients PA2 and PA5.
Similar amounts of anti-O2 and anti-O12 antibodies appeared to
be made in patients PA1 and PA4. TUBEX TF was negative for
these cases, implying the absence of cross-reacting anti-O12
antibodies.
TUBEX 12T detects typhoid better than TUBEX TF
Various TUBEX tests (see Fig. 1) were used to detect typhoid
fever from 22 culture-confirmed typhoid patients who lived in
Xinjiang Province in China. Paired sera were obtained from each
patient with a time interval of 4 – 23 days between samples, and all
sera were kept at 280uC for , 4 years before the present study.
As shown in Table S1, patients are designated as T31 – T73,
while the 1
st and 2
nd serum samples from each patient are labeled
‘a’ and ‘b’, respectively. The samples are divided into 4 major
groups (Group A – D) according to the IgM and IgG ELISA
activities to S. Typhi LPS. Categorization was done after the
TUBEX tests were performed, the latter independently of ELISA.
Thus, Group A specimens have moderate (M) to high (H) levels of
both IgM and IgG antibodies, while Group B specimens have M –
H IgM, but low (L) to negligible IgG levels of antibodies. Group C
specimens are virtually devoid of any antibodies to all 3 Salmonella
antigens, while Group D specimens have no detectable IgM
antibodies to S. Typhi LPS, but have high levels of IgG antibodies
to all 3 antigens. Group A is further sub-divided into Group A1, in
which specimens were obtained # 11 days following onset of fever,
and Group A2, in which the specimen was obtained after 17 days.
Accordingly, Group A1 comprises only ‘a’ specimens, and Group
A2 mostly ‘b’ specimens except for 2 ‘a’ specimens.
In Group A1 (10 specimens), TUBEX TF and TUBEX 12T
detected 90% and 100% of the serum samples, respectively.
However, the positive scores in TUBEX TF were modest, with
only 30% of samples having scores $ 6, the highest score being 7.
Better results were observed with TUBEX 12T (70% with scores
$ 6, highest score being 8). Both paratyphoid A tests, TUBEX PA
and TUBEX 12P, also detected the test samples with high
efficiency (80% and 100%, respectively) and with positive scores
slightly better than those of TUBEX TF. In all cases, TUBEX PA
reactivity could be blocked completely by soluble S. Typhi LPS
(see TUBEX bPA), which implicates the involvement of anti-O12
antibodies. In contrast, in TUBEX TF (see TUBEX bTF), the
reaction was essentially unaffected by S. Paratyphi A LPS,
suggesting that reactivity to be due largely to anti-O9 antibodies.
In Group A2 (17 specimens), both TUBEX TF and TUBEX
12T detected all cases except for one (94%). The odd specimen
(T71b) came from a patient whose earlier (1
st) specimen was also
negative. Again, the positive scores from TUBEX 12T (76.5%
with scores $ 6, highest score being 9) were superior to those of
TUBEX TF (35.3% with scores $ 6, highest score being 7).
TUBEX 12P also performed well (94% sensitive), but TUBEX PA
was only 58.8% positive. Reactivity in TUBEX PA was completely
abolished by soluble S. Typhi LPS in 17 cases, whereas that in
TUBEX TF was virtually unaffected by soluble S. Paratyphi A
LPS.
In Group B, both TUBEX TF and TUBEX 12T detected all 7
sera (100%). In contrast, none (0%) was detected by TUBEX PA,
while TUBEX 12P was positive in 5 cases (71.4%). Higher scores
were again obtained by TUBEX 12T over TUBEX TF. There are
2 pairs of sera in this group (from individuals T31 and T63), and in
both cases, the 1
st specimen was obtained 8 days after fever onset,
and the 2
nd specimen on day 22–23. Two other serum samples
(from patients T57 and T65) were also early (day 8–10), while the
remaining sample from patient T41 was obtained on day 24.
In Group C, which had virtually no ELISA antibodies to any of
the antigens, the TUBEX results were similarly negative in
virtually all 7 cases. There are 3 pairs of sera in this group, and in
all cases, the 1
st specimen was obtained 7–9 days after onset of
Figure 1. Schematic diagram illustrating the various types of
TUBEX tests and the various types of antibodies detected by
these. Shown are the various mAb-indicators (anti-O9, anti-O2 or anti-
O12b) and antigenic epitopes (O9, O2 O12a, O12b and O12c) found in S.
Typhi or S. Paratyphi A LPS. Arrow indicates antigenic epitope that
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nd specimen on day 21–23. The remaining single
serum was obtained on day 38, which came from patient T41
whose earlier serum sample, yielded strong reactivities in both
ELISA and TUBEX (see Group B).
Group D comprises only 3 specimens, including the early (day
9) and late (day 22) serum from patient T47 — both were strongly
positive in TUBEX 12T, TUBEX 12P and TUBEX PA, despite
having no detectable ELISA IgM antibodies to S. Typhi LPS (but
high IgG levels to all 3 antigens present). The remaining specimen
was an early (day 7) sample with similar ELISA profile, and both
this and a later (day 30) sample from the same patient (T71, see
Group B) were negative in all TUBEX tests.
Taking the whole cohort of sera together (Groups A–D), the
sensitivity of detection for IgM ELISA is 77.3% (34/44), compared
to 75.0% (33/44), 45.5% (20/44), 81.8% (36/44) and 75.0% (33/
44), for TUBEX TF, TUBEX PA, TUBEX 12T and TUBEX
12P, respectively. That is, TUBEX 12T is slightly better in
sensitivity than either IgM ELISA or TUBEX TF. If only sera that
are IgM ELISA-positive (i.e. Groups A and B) are considered, then
the sensitivities of TUBEX 12T and TUBEX TF become 97.1%
(33/34) and 94.1% (32/34), respectively.
Again, when considering the whole cohort of sera, TUBEX 12T
is superior to TUBEX TF in terms of results score. Thus, only
25% (11/44) of the sera in TUBEX TF had scores $ 6, with the
highest score being 7, compared to 56.8% (25/44) for TUBEX
12T, 52% (13/25) of these sera having scores of 8–9 (Fig. 4A).
Increase in results scores from TUBEX TF to TUBEX 12T was
observed in 59.0% (13/22) of individuals (Fig. 4B).
Fig. 5 summarizes the change in antibody titer between the 1
st
and 2
nd specimen of all 22 typhoid patients, determined by TUBEX
TF or TUBEX 12T. Results between the two tests are very similar.
Remarkably, there was no significant change in TUBEX score in
the majority (63.6% [14/22]) of patients (change defined as
difference in TUBEX score $ 2 in either or both of the TUBEX
tests). Increase in titer was observed in 5 individuals (26.3% [5/19])
whose 1
st specimen was obtained within 11 days of fever onset, and
the 2
nd specimen after a further 8–12 days. Decrease in titer was
observed in 3 patients, the 1
st specimen in 2 cases obtained after 19
Figure 2. Pictoral results showing efficacy of various TUBEX tests in detecting mAb-spiked test samples. Various mAb-indicators (anti-
O9, anti-O2 or anti-O12b) in conjunction with O9 LPS- (A) or O2 LPS-coupled (B) magnetic particles to detect various types of purified mAbs (anti-O9,
anti-O2 or anti-O12b, or combinations of these). Numericals in microwells denote individual mAb concentration (mg/ml), same for all sets of
microwells; ‘score’ denotes TUBEX results.
doi:10.1371/journal.pone.0024743.g002
Typhoid-Paratyphoid Rapid Test
PLoS ONE | www.plosone.org 4 September 2011 | Volume 6 | Issue 9 | e24743days of fever, in one of whom (patient T41), a dramatic drop in
TUBEX titer (from high to nil activity over 2 weeks) was observed.
Regression analysis was performed to examine the relationships
between the various tests (Fig. 6). Thus, it appears that the TUBEX
TF results are better correlated with those of IgM ELISA than IgG
ELISA, regardless of which Salmonella LPS was used in the ELISA
(e.g. r
2=0.598 P,0.001 for TUBEX TF vs IgM ELISA S. Typhi
LPS; r
2=0.075 P=0.073 for TUBEX TF vs IgG ELISA S. Typhi
LPS). TUBEX 12T is similar to TUBEX TF in this regard, except
that, in TUBEX 12T, best correlation was observed with IgM
ELISA S. Typhi LPS (r
2=0.50 P,0.001), and there is also
correlation with IgG ELISA (regardless of LPS type) (e.g.
r
2=0.339 P,0.001 for TUBEX 12T vs IgG ELISA S. Typhi LPS).
It is also apparent that TUBEX TF is best correlated with
TUBEX 12T (r
2=0.563 P,0.001) than with TUBEX 12P
(r
2=0.305 P=0.001) or TUBEX PA (r
2=0.155 P=0.008). On
the other hand, there is strong association between TUBEX 12P
and TUBEX PA (r
2=0.713 P,0.001), and between TUBEX 12P
and TUBEX 12T (r
2=0.668 P,0.001).
TUBEX 12P detects paratyphoid A fever better than
TUBEX PA
Similar to the above study with typhoid patients, herein the
efficiencies of detection of paratyphoid A fever by various TUBEX
andELISAtestswerecompared usingsingleserumsamplesfrom36
culture-confirmed paratyphoid A patients who lived in Yunnan
Province in China. Twenty-four of these sera were procured in
2006, and the other 12 sera in 2009; all sera were stored at 280uC.
Similar to the typhoid study, the whole cohort of sera is divided
into 4 groups (A – D) based on the IgM and IgG ELISA activities
to S. Paratyphoid A LPS (instead of S. Typhi LPS) (see Table S2).
Figure 3. Pictoral results showing efficacy of various TUBEX tests in detecting clinical samples. Sera obtained from typhoid (A) or
paratyphoid A (B) patients, or from healthy individuals (A), were examined as described in Figure 2. N1-N4, healthy individuals; T1, typhoid individual;
T2, pool of 4 typhoid patients; T3, pool of 4 other typhoid patients; PA1-PA6, paratyphoid A patients; numericals in microwells denote TUBEX scores;
ND, not done (insufficient specimen).
doi:10.1371/journal.pone.0024743.g003
Figure 4. Comparison of the results scores between TUBEX TF and TUBEX 12T in typhoid patients. Based on the frequency of the
various scores (0–10) (A), or on each individual patient (total 22 patients) (B).
doi:10.1371/journal.pone.0024743.g004
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TUBEX tests. Group A is sub-divided into Group A1 and A2, in
which the sera were procured in 2006 and 2009, respectively.
Group D is similarly sub-divided into Group D1 and Group D2. A
significant difference between this tabulation and that for the
typhoid patients is the relatively large size of Group D (especially
D1) individuals here. Another difference is that, many of the
paratyphoid sera, especially those in 2006, were procured within
the 1
st week of fever onset. In addition, unlike Group A typhoid
patients who had high levels of both IgM and IgG ELISA activities
to all 3 LPS antigens, 7 of 9 Group A1 paratyphoid patients had
only low levels of IgM ELISA antibodies to S. Paratyphoid A (but
most had high IgG levels), and no IgM ELISA antibodies to the
other LPSs. Group A1 is, in fact, quite similar to Group D1.
Thus, in Group A1, TUBEX 12P detected 6 of the 9 individuals
(66.7%), but TUBEX PA detected only 2 of them (22.2%). Both of
the latter individuals had M – H levels of IgM ELISA antibodies to
S. Paratyphoid A, and both yielded high results scores in TUBEX
PA and TUBEX 12P.
All 6 Group A2 individuals, who had M – H levels of IgM
ELISA antibodies to S. Paratyphoid A, were strongly detected by
TUBEX 12P (scores 6 – 9). Most were also detected by TUBEX
PA (83.3%, scores 3–10), but only 50% (scores 4 – 7) by TUBEX
TF.
Group B comprises a single individual with low IgM ELISA
antibodies who was negative in both TUBEX 12P and TUBEX
PA. All 4 Group C patients had no ELISA antibodies and were
negative in TUBEX PA (1 individual, marginally positive) and
TUBEX 12P.
Group D1 sera generally lacked IgM ELISA antibodies to the 3
LPS antigens but contained abundant levels of IgG antibodies. In
Group D1, TUBEX 12P detected 4 of 12 sera (33.3%), and
Figure 5. Change in antibody titer (TUBEX score) over time in individual typhoid patients. TUBEX 12T or TUBEX TF was used to examine
the 1
st and 2
nd specimen from 22 patients. Cases divided between those whose 1
st specimens were obtained less than 11 days of fever, and those
obtained after 19 days; indicated are ones showing significant rise or fall in antibody titer.
doi:10.1371/journal.pone.0024743.g005
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doi:10.1371/journal.pone.0024743.g006
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were obtained here: 50% (2/4) for TUBEX 12P, and 25% (1/4)
for TUBEX PA.
Considering the whole cohort of sera, the IgM ELISA (S.
Paratyphi LPS) (15/36 or 41.7%) is slightly less sensitive than
TUBEX 12P (52.8%). Considering the 2009 specimens only, the
corresponding statistics become 50.0% (6/12) and 66.6% (8/12),
respectively. Similarly, for 2006, the statistics are 41.7% (10/24)
and 45.8% (11/24), respectively.
A common TUBEX test for typhoid/paratyphoid A fever
and a typhoid–specific TUBEX TF test
Based on the above findings, we investigated the possibility of
combining TUBEX 12T with TUBEX 12P to establish an
efficient test to detect both typhoid and paratyphoid A fever
simultaneously. Only a preliminary study was conducted due to
shortage of test material, using available sera from a few typhoid
and paratyphoid A patients only. Indeed, we found that TUBEX
12TP, which is comprised of equal proportions of TUBEX 12T
and TUBEX 12P: (a) detected purified anti-O12 mAb (mAb
P4E8) as efficiently (32 mg/ml) as TUBEX 12T and TUBEX 12P,
and (b) detected 9 of 10 typhoid and all 3 paratyphoid sera
examined (Table S3). The results scores were similar to, or
marginally lower than, the corresponding results in TUBEX 12T
and TUBEX 12P for the typhoid and paratyphoid patients,
respectively, but were generally better than those in TUBEX TF
and TUBEX PA for the respective patients. However, in one
particular paratyphoid patient (P12), the TUBEX 12TP determi-
nation (score 4) was significantly lower than that of TUBEX 12P
(score 8). To redress this problem, we modified the combined test
using twice as much TUBEX 12P as TUBEX 12T, and in this
new test (TUBEX 12TPP) with this particular serum, an
improvement was indeed noted (score 6). Importantly, in TUBEX
12TPP, the results scores for the typhoid sera remained essentially
the same as those in TUBEX 12TP.
We further investigated the possibility of modifying TUBEX TF to
make it truly typhoid–specific, suitable as a differential test used in
conjunction with TUBEX 12TPP. Such a modification (bTF) was
found possible, by incorporating soluble S. Paratyphi A LPS in the test
as an adsorbent to remove anti-O12 antibodies (Table S1). However,
as mentioned, the problem with the existing TUBEX TF test is that
the resultsscoresare generallyweakerthan those ofTUBEX12T, and
consequently, a weak typhoid case could be misinterpreted as
negative. To overcome this problem, we investigated the possibility
of enhancing the reaction intensity in TUBEX TF by using twice as
much serum sample (with half the vol of indicator particles, of a higher
concentration). Experiments using purified anti-O9 mAb (3h1)
indicate that this modification was feasible (Table S4A). Confirmation
was found using 3 typhoid serum samples, in which TUBEX TF
scores of 5-6 were obtained instead of 2-4 (Table S4B). Moreover, in
t h ep r e s e n c eo fS. Paratyphi A LPS (blocker), the results of the
modified method (bTF) for these sera remained distinctly positive
(score 4 in all cases), while those for 6 individual paratyphoid sera used
as control were negative (score 0 – 2).
In the study, we also examined the specificity of the TUBEX
tests using sera obtained from 18-20 healthy individuals and 6-10
patients with non-Salmonella febrile illness (Table S5). None of the
subjects were positive in TUBEX PA and TUBEX 12P, but 3-4
subjects were marginally positive (score 3–4) in TUBEX TF or
TUBEX 12T. All 3 positive cases in TUBEX TF also had low IgM
ELISA activity to S. Typhi, 2 of whom were also positive in
TUBEX 12T. Only 4 specimens were available for subsequent
testing by TUBEX 12TP and TUBEX 12TPP—all were negative
(score 0) in these tests.
Discussion
We examined the assay characteristics of TUBEX TF and several
prototypic TUBEX tests (TUBEX PA, TUBEX 12T, TUBEX 12P,
TUBEX 12TP [including the variant, TUBEX 12TPP]) in the
detection of typhoid and paratyphoid A fever. These tests were
designed to detect anti-O9 (TUBEX TF), anti-O2 (TUBEX PA) or
anti-O12 (TUBEX 12T, TUBEX 12P, TUBEX 12TP) antibodies by
direct inhibition of binding of the reagent mAb to its target (see Fig. 1).
As revealed both here and in a previous study [18], these tests not only
detected the intended antibody, but also indirectly, by virtue of steric
hindrance, antibodies that bind to a neighboring epitope. That is, anti-
O12 antibodies from patients are cross-detected in TUBEX TF and
TUBEX PA, while anti-O9 antibodies are similarly detected in
TUBEX 12T and TUBEX 12TP, and anti-O2 antibodies in TUBEX
12P and TUBEX 12TP. Thus, both the anti-O9 (3h1) and anti-O2
(P1D10) mAbs clearly inhibited binding of the anti-O12 indicator
particle in TUBEX 12T, TUBEX 12P and TUBEX 12TP. However,
unexpectedly, the anti-O12 mAb (P4E8) was not inhibitory for the
anti-O9 (TUBEX TF) or anti-O2 (TUBEX PA) indicator. Since, on
the other hand, studies using sera from both typhoid and paratyphoid
A patients clearly showed anti-O12 antibodies to be present that were
responsible for the cross-detection in TUBEX TF and TUBEX PA, we
reason that patients can produce more than one type of anti-O12
antibodies. This may not be surprising since the O12 antigen is
relatively large, being comprised of a trisaccharide. This may also
explain the apparent abundance of anti-O12 antibodies in typhoid and
paratyphoid patients. A simplistic view is, there are at least 3 types of
anti-O12 antibodies, one to each of the 3 sugars, and all 3 types can
inhibit binding of the indicator anti-O12 mAb to its antigen (Fig. 1).
Only one type (anti-O12a), however, is capable of blocking the anti-O9
or anti-O2 indicator. The high clinical sensitivity of O12-based
TUBEX tests may thus be attributed to the strategic location of the
antigenic epitope (O12b) in the LPS to which mAb P4E8 binds.
Accordingly, in both the typhoid and paratyphoid patients, the anti-
O12 detection tests (TUBEX 12T and TUBEX12P) detected more
cases than the anti-O9 (TUBEX TF) or anti-O2 (TUBEX PA) test.
More impressively, these tests also yielded significantly higher results
scores in the majority of patients than the corresponding tests. Thus, in
the case of typhoid patients, whereas only about a quarter of the
subjects obtained the highest TUBEX TF scores of 6–7, roughly the
same proportion obtained scores of 8–9 in TUBEX 12T. Since both
tests are similar in sensitivity in detecting mAb P4E8, and both detect a
common anti-O9 antibody population, very likely, the superiority of
TUBEX 12T is due to the additional detection of anti-O12b and anti-
O12c antibodies. Regression analysis supports this, and in addition, it
seems that IgG antibodies are also involved. Thus, enhanced TUBEX
12T scores are best seen in ELISA Group A2 (late-stage) individuals
who have high ELISA levels of both IgM and IgG classes, whereas in
Group B individuals who have IgM but no IgG antibodies,there is little
difference between the TUBEX 12T and TUBEX TF scores.
We demonstrated that it is possible to combine TUBEX 12T
with TUBEX 12P to produce a combined test (TUBEX 12TP) for
typhoid and paratyphoid fever. Such a test is desirable since both
diseases require similar clinical attention, and this can save
resources, time, and clinical material. The most important
requirement is that such a test can distinguish these Salmonella
infections from other non-Salmonella febrile diseases such as dengue
fever and malaria. Since O12 is unique to Salmonella, and based on
the limited observation with control sera in the present study as
well as from previous TUBEX TF findings [17], TUBEX 12TP
seems to have the desired specificity. By mixing different
proportions of TUBEX 12T and TUBEX 12P together to achieve
the desired O9:O2 antigenic ratio (O12 remaining constant), we
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detection due to the apparently higher amounts of anti-O2
antibodies produced than anti-O12 antibodies in some patients.
While TUBEX 12TP (or 12TPP) is intended to be used as a
screening test for both typhoid and paratyphoid A, it actually casts
a wider net and captures paratyphoid B as well, including
infections caused by other Salmonella members belonging to
serogroup A, B and D, that manage to invade the bloodstream
and stimulate a systemic antibody response. However, most of the
time and in most places, it will be typhoid and paratyphoid A that
will be responsible for the reactivity. If, for epidemiological reasons
there is need to distinguish between these two diseases, we showed
that this can be done by re-testing the specimen in TUBEX TF in
the presence of a blocker (S. Paratyphi A LPS) to remove the anti-
O12 antibodies. Sera that contain anti-O9 antibodies i.e. from
typhoid patients, will be positive in the differential test.
An extremely important inclusion in the study is the use of
ELISA to characterize the sera independently and objectively.
Though rather cumbersome and time-consuming for routine use,
this highly sensitive test quantifies the amount of IgM or IgG
antibodies to S. Typhi (O9
+ O12
+) LPS, S. Paratyphi A (O2
+
O12
+) LPS, or S. Typhimurium (O4
+ O12
+) LPS. Thus, the
relevant ELISA results found in the present study correlated very
well with those of the TUBEX tests, corroborating the fact that
TUBEX reactions are truly antibody-mediated. Regression
analysis suggests that IgM antibodies, rather than IgG antibodies,
are responsible for the TUBEX inhibitions. This agrees well with a
previous experimental study [19] and a clinical study [12];
however, the latter also indirectly implied that IgG antibodies,
when present in great abundance, can facilitate the inhibitory
activity of the IgM antibodies. In the present study, a similar
supporting role of IgG antibodies may explain the enhanced
TUBEX 12T scores seen in some patients, including patients (e.g.
T47) who seemed to have little or no IgM ELISA antibodies.
The IgM ELISA results correlated well with those of TUBEX
TF or TUBEX 12T regardless of LPS or TUBEX type, suggesting
that anti-O12 antibodies are predominantly detected by the
TUBEX tests. However, only a subset of these antibodies (anti-
O12a) is detected by TUBEX TF, and these antibodies are also
responsible for the cross-detection of typhoid patients by TUBEX
PA and TUBEX 12P. Thus, these results strongly argues against
any claim that ELISA or lateral-flow tests based on S. Typhi or S.
Paratyphi A LPS, or the O-antigen Widal tests, can discriminate
between typhoid and paratyphoid A fever.
Categorization of the study cohort into the 4 ELISA groups
allows a greater insight into disease pathogenesis and a more
precise assessment of TUBEX performance. Thus, it appears that
Group B represents a very early stage in typhoid, since IgM
antibodies, but no IgG antibodies, were made to S. Typhi.
Accordingly, the relevant specimens were procured early in the
infection (8–10 days), and secondly, IgG antibodies were indeed
found in later specimens (Group A2) obtained from 2 patients
(T57 and T65). However, in 2 other patients (T31 and T63), IgM
antibodies only (without IgG) were also found in the 2
nd specimen
obtained 2 weeks after the first. This suggests an absence of class-
switching. This is also apparent in patient T41, but interestingly in
this case, the 2
nd specimen (see Group C) obtained 2 weeks later
showed a total absence of antibody activity. Thus, altogether, the
findings suggest that it may not be uncommon (3/22 or 13.6%) to
find individuals who mount an antibody response to Salmonella LPS
antigens that fails to undergo class-switching (like a true thymus-
independent response), and seemingly, the response then disap-
pears completely. To our knowledge, this intriguing observation
has not been reported previously for any disease. From a
diagnostic viewpoint, these early specimens are very efficiently
detected by both TUBEX TF and TUBEX 12T, implying that
IgM anti-O9 antibodies are made abundantly early in infection. In
stark contrast, no anti-O12a antibodies seem to be made at this
stage since TUBEX PA was negative for all samples examined. On
the other hand, IgM anti-O12b or anti-O12c antibodies are
produced since TUBEX 12P was positive for some of the cases,
and IgM ELISA was positive for all LPS types.
Group A1 probably also represents an early disease stage, but
here, the antibody response has undergone normal class-switching.
Thus, both IgM and IgG anti-O9 antibodies were produced –
hence, the high efficiency of detection by both TUBEX TF and
TUBEX 12T. It is possible that patients in this group had a
previous exposure to S. Typhi organisms, and the rapid IgG
production is due to an anamnestic response. Also produced in
these patients are IgM anti-O12a and other anti-O12 antibodies,
which could account for the high detection rates of TUBEX PA
and TUBEX 12P.
Group A2 probably represents a disease stage subsequent to
that of Group A1 – convalescence. Accordingly, TUBEX TF,
TUBEX 12T and TUBEX 12P all performed very well here.
Surprisingly, however, TUBEX PA was only moderately sensitive.
A possible explanation is, either the anti-O12a antibody response
is terminated in some individuals, or IgG anti-O12a antibodies are
now made that do not inhibit in TUBEX PA.
Group C individuals (3 patients with 3 serum pairs) produced
little or no ELISA or TUBEX antibodies to any of the Salmonella
antigens. The most likely explanation is that these individuals are
naturally (genetically) non-responders; alternatively, the offending
organisms in these people were eliminated by early antibiotic
treatment before they could stimulate the immune response.
It is more difficult to explain the ELISA profile (nil-IgM, high
IgG) in Group D. One possibility is that the IgM antibodies, which
are more fragile than IgG antibodies [20], are denatured due to
storage of the specimen. Alternatively, in the case where both the
1
st and 2
nd specimens share a similar ELISA profile, this may be
related to antibody production.
The foregoing suggests the possibility that there is a temporal
pattern of antibody production to the various LPS antigens. Thus,
the anti-O9 response appears to be initiated very early during
infection, and is sustained for a long time. Others, such as the anti-
O12a response, seem to develop later and are prone to change or
earlytermination. Several examplescan befoundinthe studycohort
which show either a rise or fall in antibody titers in TUBEX TF or
TUBEX 12T over a 4–16 day period (Fig. 5). As expected, antibody
increase was observed in cases in which the 1
st specimens were
obtained early in infection, whereas antibody decrease was usually
associated with late-phase 1
st specimens. However, a surprising
finding is that, the majority (64%) of patients showed no significant
change in TUBEX or ELISA titers over time (Fig. 5). This is an
important revelation,asitchallengesthebeliefthat useof paired sera
in the Widal test is superior to using single serum samples.
Similar analysis can be made of the paratyphoid ELISA groups.
The sera here were obtained from a different region from the
typhoid sera, and unusually, most were obtained in the 1
st week of
disease. One striking difference between these sera and the typhoid
sera is the relatively large group of paratyphoid patients in Group
D who generally made IgG antibodies, but no IgM antibodies, to
the 3 Salmonella antigens. Furthermore, unlike Group A typhoid
patients who produced vast amounts of both IgM and IgG
antibodies to all 3 antigens, Group A1 paratyphoid patients
produced only small amounts of IgM antibodies (but high IgG) -
very similar, in fact, to Group D individuals.
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paratyphoid sera had deteriorated, which affected the more fragile
IgM antibodies but not the IgG antibodies. Alternatively, these are
early-stage sera obtained from hosts in whom IgM production had
not begun; the unexpected presence of IgG antibodies could
perhaps be explained by previous vaccination against S. Typhi.
In favor of deterioration is the observation that paratyphoid sera
obtained more recently in 2009 (Group A2 and D2) generally
performed better in the TUBEX tests than those obtained in 2006
(Groups A1 and D1) (see below). Indeed, sera procured even more
recently (2010), from a different geographical region, were found
to be efficiently detected by TUBEX 12TPP (our unpublished
observations). In addition, contrary to expectation, several serum
samples obtained very early in disease in 2006 (e.g. P01, P12, P19)
exhibited strong TUBEX 12P scores, while several others obtained
very late in disease (e.g. P07, P11, P20), were negative in the test.
Furthermore, the overall sensitivities of detection of the whole
cohort of paratyphoid patients by TUBEX 12P and TUBEX PA
(52.8% and 28.6%, respectively) are significantly lower than those
for typhoid patients by TUBEX 12T and TUBEX TF (81.8% and
75.0%, respectively). This is puzzling since TUBEX 12T and
TUBEX 12P, for instance, have very similar assay sensitivities.
Inclusion of an independent, objective test in the study was
instructive. Thus, similar differences were also found in the IgM
ELISA between the typhoid (77.3%) and paratyphoid (44.4%)
sera, including the high concordance between the TUBEX and
ELISA results for individual cases, suggesting that the problem lies
in the specimen and not the test. A surprising finding here is that
the overall ELISA results are, in fact, marginally poorer than the
corresponding TUBEX results. The exceedingly low detection rate
by TUBEX PA of the paratyphoid patients stands in stark contrast
to previous findings with the test [18], again implicating specimen
as the possible cause of the difference.
If only sera that are IgM ELISA-positive are considered, then
the sensitivities of TUBEX 12T and TUBEX 12P increase to
97.1% and 75.0% for the typhoid and paratyphoid patients,
respectively. Moreover, if the IgM-positive paratyphoid sera are
subdivided into those obtained in 2009 (Group A2) or 2006
(Group A1), it is evident that TUBEX 12P can be very sensitive if
given the appropriate specimen (100%, 2009 specimens).
Another factor often taken for granted which can also adversely
affect the true worth of antibody tests is the use of culture as the gold
standard in diagnosis. Based on this yardstick, antibody tests cannot
be any more sensitive than culture; in fact, they are more likely to be
inferior because culture-positive cases are often inadvertently
selected from the early phase of the disease when the organisms
circulate freely in the blood while antibody production may have
only just begun. The problem here is, culture itself is generally
known to be only about 60% or less sensitive; hence, there exists a
potentially large group of true typhoid patients who are culture-
negative but who could be antibody-positive — patients in late-
phase disease, for example. How big this group is will determine the
realsensitivityofthe antibody tests— andthat ofculture.It ishighly
possible that antibody tests can indeed be more sensitive than
culture and a better indicator of infection. We do not have such a
group in the present study but previously [11], we have identified
several individuals of the said description. We have also seen similar
cases that are apparently healthy (non-febrile) and in whom the
TUBEX TF reactions were confirmed to be real by O9 LPS
absorption. These could be individuals who have a subclinical or
asymptomatic S.Typhi infection, in whom disease is modulated by
the same protective antibodies that also serve as diagnostic markers
(e.g. anti-O9), or people who are chronic typhoid carriers.
Similarly, if the group of culture-negative, antibody-positive
febrile patients is considered as control-negative in a study without
further qualification, estimation of assay specificity will be
adversely affected because such cases will be regarded as false-
positives. One way to avoid this uncertainty, as demonstrated
elegantly by Ley et al [17], is to use as control typhoid-negative, a
group that is not only negative for S.Typhi culture, but also
culture-positive for some other organism presumed to be the cause
of the febrile illness. Thus, based on such a group comprising 106
randomly-selected individuals, they found a specificity of 89%
using TUBEX TF. Organisms grown were varied, but Salmonella
organisms other than S.Typhi were obtained from 49 individuals.
Instructively, when this sub-group was omitted from the
calculation, the specificity rose to 97%. TUBEX TF was positive
in 18% of these cases — we suspect the organisms found in these
individuals might be S.Enteriditis or other Salmonella members that
possess the O12 or O9 antigen, or both.
Materials and Methods
Study populations
Twenty-two culture-confirmed typhoid patients who lived in
Xinjiang Province in China, and 36 culture-confirmed paratyphoid
A patients from Yunnan Province in China, were used. All patients
presented with fever for at least 3 days in the 1
st week of illness at the
time of the hospital or clinic visit in 2006 or 2009. Patients provided
written informed consent for participation in the study and blood
from each patient was obtained by venipuncture according to
guidelines approved by the Institutional Review Board in Xinjiang
or Yunnan, China. The typhoid patients recruited in 2006, aged 7
to 19 years (median,14.5 years),had fever foran averageof 8.5days
(range, 7–35 days). The 24 paratyphoid A patients recruited in
2006, 16 to 59 years old (median, 31.5 years), had fever for 4.0 days
(range, 2–44 days); while 12 other paratyphoid A patients from
2009, aged 15 to 64 years (median, 22.5 years), had fever for 7.5
days (range, 5–12 days). Twenty healthy healthcare workers from
Beijing and 10 non-Salmonella febrile patients from Hebei, China,
were used as control subjects.
Sera used in the preliminary studies were the same specimens
obtained from typhoid and paratyphoid A patients described
previously [18].
Blood culture
Blood (4 – 8 mL) from adult subjects ($12 years) was inoculated
into BD Bactec Plus Aerobic/F culture broth (Becton Dickinson,
Sparks, MD), that (2–4 mL) from children into BD Bactec Peds
Plus/F medium (BD). The broth was incubated aerobically at
37uC; when growth was apparent, or after 7 days, subculture was
made onto blood and MacConkey agar. Salmonella-suspect colonies
were identified by standard biochemical testing and, where
appropriate, serotyped by slide agglutination using Salmonella O
and H group-specific antisera obtained from the Chengdu
Institute of Biological Products, China.
TUBEX tests
a) Antibody-coupled indicator particles: Anti-O2 and anti-O12
mAb produced previously [18], was coupled to blue latex
particles (1.0 mm; Merck) by passive adsorption as described
previously [21]. Briefly, equal volumes of antibody (1 mg/
mL) and latex particles (1% w/v suspension) were mixed in
0.1M glycine buffer (pH 8.2) containing 0.9% NaCl (GBS
buffer) and incubated on a roller at 4uC for 16 hr. The
particles were blocked with 2% BSA in GBS buffer and then
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and once with GBS buffer containing 1% BSA. Finally, the
particles were resuspended in 1% BSA-GBS buffer.
b) LPS antigen-coupled magnetic particles: O9 LPS was
obtained from Sigma Chemical, St. Louis, MO, and O2
LPS was prepared by phenol extraction as described
previously [18]. LPS (0.6–1.0 mg/mL) was coupled to
magnetic latex particles (0.8 mm; Merck) by passive adsorp-
tion. The coupling concentration of O9 LPS and O2 LPS was
1 mg/mL and 0.63 mg/ml, respectively [21].
b) TUBEX TF was obtained from IDL Biotech, Sollentuna,
Sweden; the Blue and Brown reagents from this kit were also
used in the prototypic TUBEX tests described in the study
(TUBEX PA, TUBEX 12T, TUBEX 12P, TUBEX 12TP
and TUBEX 12TPP).
c) Procedure: All tests were performed according to the
manufacturer’s instructions for TUBEX TF, except that a
smaller vol of reagents or specimen was used. Briefly, 25 mLo f
Brown reagent (antigen-coupled magnetic particles) were
placed in a well of a specially-designed reaction vessel (made
up of 6 small, identical V-shaped wells). The test serum (25 mL)
was then added and mixed with the Brown reagent using a
pipette. The mixture was stood for 2 min. Blue reagent
(antibody-coupled indicator particles; 50 mL) was then added,
and the whole set of reaction wells was sealed with adhesive
tape and shaken rapidly for 2 min in an automatic portable
shaker (TUMIX, IDL Biotech). The set of reaction wells was
then stood for about 2 min on the magnet stand supplied, and
the resulting color of the supernatant read by eye and scored
against the color chart provided. The results were graded from
0 (red, most negative) to 10 (blue, most positive), with scores #
2 considered as negative in the study.
The differential TUBEX tests (TUBEX bTF, TUBEX bPA and
TUBEX bTFX) were performed as described previously [18].
Briefly, 5 mL (TUBEX bTF and TUBEX bPA) or 10 mL (TUBEX
bTFX) LPS blocker (10 mg/mL S. Typhi LPS or S. Paratyphi A
LPS in GBS buffer) or GBS buffer (control) were added to the
reaction well containing the Brown reagent, and the rest of the
procedure then followed as described above.
Anti-LPS ELISA
The direct ELISA tests used were described previously [18].
Briefly, Immunolon-2 microplates (Thermo, Milford, MA) coated
with S. Typhi LPS (1 mg/mL; Sigma Chemical, St. Louis, MO), S.
Paratyphi A LPS (1 mg/mL; own production), or S. Typhimurium
LPS (1 mg/mL; Calbiochem, La Jolla, CA) were incubated with
patient’s serum (1:100 dilution) for 30 min at room temperature.
The plates were washed and incubated with horseradish
peroxidase-labeled mouse anti-human IgG or goat anti-human
IgM (m) (Invitrogen, Camanillo, CA) for 30 min at RT. After
washing, substrate (3,39, 5,59 – tetramethylbenzidine) was added
and incubated for 10 min at RT. Results were read at 450 nm in a
TECAN Sunrise reader. Positive results were scored as low (‘‘L’’),
medium (‘‘M’’), or high (‘‘H’’) with respect to the ELISA levels
found in healthy subjects: mean + 1S D# L , mean + 2 SD;
mean + 2S D# M , mean + 4 SD; H $ mean + 4 SD.
Statistics
Regression analysis was performed using Prism 3 (Graph-Pad
Software); P,0.05 was considered significant.
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